Annual SGA
$39.84 M
+$33.45 M+523.12%
December 31, 2023
Summary
- As of February 26, 2025, BRNS annual SGA is $39.84 million, with the most recent change of +$33.45 million (+523.12%) on December 31, 2023.
- During the last 3 years, BRNS annual SGA has risen by +$29.36 million (+280.17%).
- BRNS annual SGA is now at all-time high.
Performance
BRNS SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$13.42 M
+$6.22 M+86.36%
September 30, 2024
Summary
- As of February 26, 2025, BRNS quarterly SGA is $13.42 million, with the most recent change of +$6.22 million (+86.36%) on September 30, 2024.
- Over the past year, BRNS quarterly SGA has stayed the same.
- BRNS quarterly SGA is now -30.70% below its all-time high of $19.36 million, reached on December 31, 2022.
Performance
BRNS Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$794.80 M
-$57.83 M-7.85%
September 30, 2024
Summary
- As of February 26, 2025, BRNS TTM SGA is -$794.80 million, with the most recent change of -$57.83 million (-7.85%) on September 30, 2024.
- Over the past year, BRNS TTM SGA has dropped by -$835.03 million (-2075.65%).
- BRNS TTM SGA is now -1277.00% below its all-time high of -$57.72 million.
Performance
BRNS TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
BRNS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +523.1% | 0.0% | -2075.7% |
| 3 y3 years | +280.2% | -30.7% | -6607.8% |
| 5 y5 years | - | +8.5% | -3625.3% |
BRNS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +523.1% | -30.7% | +224.1% | -118.4% | at low |
| 5 y | 5-year | at high | +523.1% | -30.7% | +224.1% | -1277.0% | at low |
| alltime | all time | at high | +523.1% | -30.7% | +224.1% | -1277.0% | at low |
Barinthus Biotherapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $13.42 M(+86.4%) | $40.23 M(+44.9%) |
| Jun 2024 | - | $7.20 M(+20.1%) | $27.77 M(-17.6%) |
| Mar 2024 | - | $5.99 M(-56.0%) | $33.70 M(-15.4%) |
| Dec 2023 | $39.84 M(+523.1%) | $13.62 M(+1316.8%) | $39.84 M(-12.6%) |
| Sep 2023 | - | $961.00 K(-92.7%) | $45.59 M(+34.8%) |
| Jun 2023 | - | $13.13 M(+8.2%) | $33.82 M(+63.5%) |
| Mar 2023 | - | $12.14 M(-37.3%) | $20.69 M(+69.4%) |
| Dec 2022 | $6.39 M | $19.36 M(-279.1%) | $12.21 M(+363.7%) |
| Sep 2022 | - | -$10.81 M(-395.2%) | $2.63 M(-90.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $3.66 M(-62.6%) | $27.00 M(+7.5%) |
| Dec 2021 | $25.12 M(+139.7%) | - | - |
| Dec 2021 | - | $9.79 M(+726.5%) | $25.12 M(+10.4%) |
| Sep 2021 | - | $1.18 M(-90.4%) | $22.75 M(+0.9%) |
| Jun 2021 | - | $12.37 M(+596.2%) | $22.55 M(+102.3%) |
| Mar 2021 | - | $1.78 M(-76.1%) | $11.14 M(+6.3%) |
| Dec 2020 | $10.48 M | $7.42 M(+659.6%) | $10.48 M(+242.6%) |
| Sep 2020 | - | $977.00 K(+0.7%) | $3.06 M(+46.9%) |
| Jun 2020 | - | $970.00 K(-12.8%) | $2.08 M(+87.2%) |
| Mar 2020 | - | $1.11 M | $1.11 M |
FAQ
- What is Barinthus Biotherapeutics annual SGA?
- What is the all time high annual SGA for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual SGA year-on-year change?
- What is Barinthus Biotherapeutics quarterly SGA?
- What is the all time high quarterly SGA for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly SGA year-on-year change?
- What is Barinthus Biotherapeutics TTM SGA?
- What is the all time high TTM SGA for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics TTM SGA year-on-year change?
What is Barinthus Biotherapeutics annual SGA?
The current annual SGA of BRNS is $39.84 M
What is the all time high annual SGA for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual SGA is $39.84 M
What is Barinthus Biotherapeutics annual SGA year-on-year change?
Over the past year, BRNS annual SGA has changed by +$33.45 M (+523.12%)
What is Barinthus Biotherapeutics quarterly SGA?
The current quarterly SGA of BRNS is $13.42 M
What is the all time high quarterly SGA for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly SGA is $19.36 M
What is Barinthus Biotherapeutics quarterly SGA year-on-year change?
Over the past year, BRNS quarterly SGA has changed by $0.00 (0.00%)
What is Barinthus Biotherapeutics TTM SGA?
The current TTM SGA of BRNS is -$794.80 M
What is the all time high TTM SGA for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high TTM SGA is -$57.72 M
What is Barinthus Biotherapeutics TTM SGA year-on-year change?
Over the past year, BRNS TTM SGA has changed by -$835.03 M (-2075.65%)